Per- and Polyfluoroalkyl Substances and Obesity, Type 2 Diabetes and Non-alcoholic Fatty Liver Disease: A Review of Epidemiologic Findings

Overview

Journal Toxicol Environ Chem

Specialty Chemistry

Date 2020 Dec 11

PMID 33304027

Citations 24

Authors

Weipeng Qi

John M Clark

Alicia R Timme-Laragy

Yeonhwa Park

Affiliations

Soon will be listed here.

Abstract

Per- and polyfluoroalkyl substances, a group of fluoro-surfactants widely detected in the environment, wildlife and humans, have been linked to adverse health effects. A growing body of literature has addressed their effects on obesity, diabetes and non-alcoholic fatty liver disease/ non-alcoholic steatohepatitis. This review summarizes the brief historical use and chemistry of per- and polyfluoroalkyl substances, routes of human exposure, as well as the epidemiologic evidence for associations between exposure to per- and polyfluoroalkyl substances and the development of obesity, diabetes and non-alcoholic fatty liver disease/ non-alcoholic steatohepatitis. We identified 22 studies on obesity and 32 studies on diabetes, while only 1 study was found for non-alcoholic fatty liver disease/ non-alcoholic steatohepatitis by searching PubMed for human studies. Approximately 2/3 of studies reported positive associations between per- and polyfluoroalkyl substances exposure and the prevalence of obesity and/or type 2 diabetes. Causal links between per- and polyfluoroalkyl substances and obesity, diabetes and non-alcoholic fatty liver disease/ non-alcoholic steatohepatitis, however, require further large-scale prospective cohort studies combined with mechanistic laboratory studies to better assess these associations.

Citing Articles

Per- and poly-fluoroalkyl substances as forever chemicals in drinking water: Unraveling the nexus with obesity and endocrine disruption - A mini review.

Pezeshki H, Rajabi S, Hashemi M, Moradalizadeh S, Nasab H Heliyon. 2025; 11(4):e42782.

PMID: 40066031 PMC: 11891678. DOI: 10.1016/j.heliyon.2025.e42782.

Per- and Polyfluoroalkyl Substances and Outcomes Related to Metabolic Syndrome: A Review of the Literature and Current Recommendations for Clinicians.

Hall A, Braun J Am J Lifestyle Med. 2025; 19(2):211-229.

PMID: 39981556 PMC: 11836584. DOI: 10.1177/15598276231162802.

Exposure to per- and polyfluoroalkyl substances and alterations in plasma microRNA profiles in children.

Li Y, Baumert B, Stratakis N, Goodrich J, Wu H, Liu S Environ Res. 2024; 259:119496.

PMID: 38936497 PMC: 11847561. DOI: 10.1016/j.envres.2024.119496.

The Impact of the Aryl Hydrocarbon Receptor on Antenatal Chemical Exposure-Induced Cardiovascular-Kidney-Metabolic Programming.

Tain Y, Hsu C Int J Mol Sci. 2024; 25(9).

PMID: 38731818 PMC: 11083012. DOI: 10.3390/ijms25094599.

Changes in plasma concentrations of per- and Polyfluoroalkyl substances after bariatric surgery in adolescents from the Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) study.

Baumert B, Eckel S, Goodrich J, Li Z, Stratakis N, Walker D Sci Total Environ. 2024; 930:172840.

PMID: 38685432 PMC: 11103488. DOI: 10.1016/j.scitotenv.2024.172840.

References

Hamid H, Li L, Grace J . Review of the fate and transformation of per- and polyfluoroalkyl substances (PFASs) in landfills. Environ Pollut. 2017; 235:74-84. DOI: 10.1016/j.envpol.2017.12.030. View

Hoffman K, Webster T, Bartell S, Weisskopf M, Fletcher T, Vieira V . Private drinking water wells as a source of exposure to perfluorooctanoic acid (PFOA) in communities surrounding a fluoropolymer production facility. Environ Health Perspect. 2010; 119(1):92-7. PMC: 3018506. DOI: 10.1289/ehp.1002503. View

Prevedouros K, Cousins I, Buck R, Korzeniowski S . Sources, fate and transport of perfluorocarboxylates. Environ Sci Technol. 2006; 40(1):32-44. DOI: 10.1021/es0512475. View

Becker A, Gerstmann S, Frank H . Perfluorooctanoic acid and perfluorooctane sulfonate in two fish species collected from the Roter Main River, Bayreuth, Germany. Bull Environ Contam Toxicol. 2009; 84(1):132-5. DOI: 10.1007/s00128-009-9896-0. View

Tittlemier S, Pepper K, Seymour C, Moisey J, Bronson R, Cao X . Dietary exposure of Canadians to perfluorinated carboxylates and perfluorooctane sulfonate via consumption of meat, fish, fast foods, and food items prepared in their packaging. J Agric Food Chem. 2007; 55(8):3203-10. DOI: 10.1021/jf0634045. View

Becker A, Gerstmann S, Frank H . Perfluorooctane surfactants in waste waters, the major source of river pollution. Chemosphere. 2008; 72(1):115-21. DOI: 10.1016/j.chemosphere.2008.01.009. View

Christensen K, Raymond M, Meiman J . Perfluoroalkyl substances and metabolic syndrome. Int J Hyg Environ Health. 2018; 222(1):147-153. DOI: 10.1016/j.ijheh.2018.08.014. View

Conway B, Badders A, Costacou T, Arthur J, Innes K . Perfluoroalkyl substances and kidney function in chronic kidney disease, anemia, and diabetes. Diabetes Metab Syndr Obes. 2018; 11:707-716. PMC: 6244585. DOI: 10.2147/DMSO.S173809. View

Gleason J, Post G, Fagliano J . Associations of perfluorinated chemical serum concentrations and biomarkers of liver function and uric acid in the US population (NHANES), 2007-2010. Environ Res. 2014; 136:8-14. DOI: 10.1016/j.envres.2014.10.004. View

10.

Alderete T, Jin R, Walker D, Valvi D, Chen Z, Jones D . Perfluoroalkyl substances, metabolomic profiling, and alterations in glucose homeostasis among overweight and obese Hispanic children: A proof-of-concept analysis. Environ Int. 2019; 126:445-453. PMC: 6555482. DOI: 10.1016/j.envint.2019.02.047. View

11.

Gallo V, Leonardi G, Genser B, Lopez-Espinosa M, Frisbee S, Karlsson L . Serum perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) concentrations and liver function biomarkers in a population with elevated PFOA exposure. Environ Health Perspect. 2012; 120(5):655-60. PMC: 3346788. DOI: 10.1289/ehp.1104436. View

12.

Jensen R, Glintborg D, Timmermann C, Nielsen F, Kyhl H, Andersen H . Perfluoroalkyl substances and glycemic status in pregnant Danish women: The Odense Child Cohort. Environ Int. 2018; 116:101-107. DOI: 10.1016/j.envint.2018.04.010. View

13.

Bach C, Vested A, Jorgensen K, Bonde J, Henriksen T, Toft G . Perfluoroalkyl and polyfluoroalkyl substances and measures of human fertility: a systematic review. Crit Rev Toxicol. 2016; 46(9):735-55. DOI: 10.1080/10408444.2016.1182117. View

14.

Yamaguchi M, Arisawa K, Uemura H, Katsuura-Kamano S, Takami H, Sawachika F . Consumption of seafood, serum liver enzymes, and blood levels of PFOS and PFOA in the Japanese population. J Occup Health. 2013; 55(3):184-94. DOI: 10.1539/joh.12-0264-oa. View

15.

Boulanger B, Vargo J, Schnoor J, Hornbuckle K . Evaluation of perfluorooctane surfactants in a wastewater treatment system and in a commercial surface protection product. Environ Sci Technol. 2005; 39(15):5524-30. DOI: 10.1021/es050213u. View

16.

Lehmler H . Synthesis of environmentally relevant fluorinated surfactants--a review. Chemosphere. 2005; 58(11):1471-96. DOI: 10.1016/j.chemosphere.2004.11.078. View

17.

Mancini F, Rajaobelina K, Praud D, Dow C, Antignac J, Kvaskoff M . Nonlinear associations between dietary exposures to perfluorooctanoic acid (PFOA) or perfluorooctane sulfonate (PFOS) and type 2 diabetes risk in women: Findings from the E3N cohort study. Int J Hyg Environ Health. 2018; 221(7):1054-1060. DOI: 10.1016/j.ijheh.2018.07.007. View

18.

Andersen C, Fei C, Gamborg M, Nohr E, Sorensen T, Olsen J . Prenatal exposures to perfluorinated chemicals and anthropometry at 7 years of age. Am J Epidemiol. 2013; 178(6):921-7. DOI: 10.1093/aje/kwt057. View

19.

Koshy T, Attina T, Ghassabian A, Gilbert J, Burdine L, Marmor M . Serum perfluoroalkyl substances and cardiometabolic consequences in adolescents exposed to the World Trade Center disaster and a matched comparison group. Environ Int. 2017; 109:128-135. PMC: 5660646. DOI: 10.1016/j.envint.2017.08.003. View

20.

Papadopoulou E, Poothong S, Koekkoek J, Lucattini L, Padilla-Sanchez J, Haugen M . Estimating human exposure to perfluoroalkyl acids via solid food and drinks: Implementation and comparison of different dietary assessment methods. Environ Res. 2017; 158:269-276. DOI: 10.1016/j.envres.2017.06.011. View